Advertisement

Topics

Shiseido Company, Limited Company Profile

01:10 EDT 23rd October 2018 | BioPortfolio


News Articles [73 Associated News Articles listed on BioPortfolio]

Shiseido Company, Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28072018] Prices from USD $175

Shiseido Company, Limited Strategy, SWOT and Corporate Finance ReportSummaryShiseido Company, Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and infor...

SHISEIDO znovu zavádí novou kolekci make-upů soustředěnou na čtyři inovativní textury

NOVĚ VYTVOŘENÁ KRÁSA. KRÁSA VYTVOŘENÁ S DUŠÍ. NEW YORK, 31. července 2018 /PRNewswire/ -- Opětovné uvedení make-upu SHISEIDO je nejnovější vzrušující a inovativní kapitola v Read ...

Shiseido Company, Ltd. ADR 2018 Q1 - Results - Earnings Call Slides

SHISEIDO celebra lanzamiento internacional de su nueva colección de maquillaje en Tokio, Japón

TOKIO, 1 de agosto de 2018 /PRNewswire/ -- Antes de su lanzamiento oficial internacional que se llevará a cabo el 15 de agosto, SHISEIDO, es Read more...

SHISEIDO Re-launches Its Hero Serum, Ultimune Power Infusing Concentrate With Global ...

With Ultimune Power Infusing Concentrate taking center stage, this series of events represents a significant milestone in SHISEIDO's brand rejuvenation journey, underpinning the brand's VISION Rea...

SHISEIDO bringt sein Hero Serum, Ultimune Power Infusing Concentrate, zurück, feiert weltweit ...

Mit den Events und Ultimune Power Infusing Concentrate im Rampenlicht feiert SHISEIDO einen bedeutenden Meilenstein bei der Wiederbelebung seiner Marke in Rahmen seiner VISION 2020-Strategie. Re...

Global and Asia Instant Adhesive Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Fagron NV : Disclosure of received notification

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2018 - 7:00am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major sha...

Drugs and Medications [1325 Associated Drugs and Medications listed on BioPortfolio]

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

Shiseido white lucent brightening spot-control foundation (refill) [SHISEIDO AMERICA INC.]

SHISEIDO WHITE LUCENT Brightening Spot-Control Foundation (Refill)

Shiseido suncare ultimate [SHISEIDO AMERICA INC.]

SHISEIDO ULTIMATE SUN PROTECTION LOTION N SPF 60 • PA+++FOR FACE/BODY

Shiseido suncare extra smooth [SHISEIDO AMERICA INC.]

SHISEIDO EXTRA SMOOTH SUN PROTECTION LOTION N SPF 38•PA++ FOR FACE/BODY

Shiseido suncare ultimate [SHISEIDO AMERICA INC.]

SHISEIDO ULTIMATE SUN PROTECTION CREAM N SPF 55•PA+++ FOR FACE

Clinical Trials [77 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery

During laparoscopy, administration of cold and dry carbon dioxide (CO2) leads to hypothermia. Different types of gas conditioning have been studied in order to prevent this specific hypoth...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Companies [1521 Associated Companies listed on BioPortfolio]

Shiseido Company, Limited

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Shiseido Co., Ltd.

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Shiseido Company, Limited" on BioPortfolio

We have published hundreds of Shiseido Company, Limited news stories on BioPortfolio along with dozens of Shiseido Company, Limited Clinical Trials and PubMed Articles about Shiseido Company, Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Shiseido Company, Limited Companies in our database. You can also find out about relevant Shiseido Company, Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record